Heuppraktijk
ActiveHeuppraktijk has been active since 2013 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €61k and a net result of €42k. Equity remains stable across the filed fiscal years (±0% per year). Its solvency ranks better than 12% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
60
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability75▼-13
Solvency32▲+6
Growth52▲+20
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €3.5k at 30 days acceptable
Liquidity tight (current ratio 1.16 against 0.97 in 2024; short-term debt: 81.4% and cash: 5.8% of total assets), and 92.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Nine signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
7.4%
Return on assets
5.1%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 12% of 16527 sector peers (2025).
NBB · sector comparisonPosition among 16527 sector peers
Solvency
better than 12%
← weakest
strongest →
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year €61k
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
1 d early
2024
57 d early
2023
9 d late
2022
21 d early
2021
31 d late
2020
3 d early
2019
21 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
21-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€61k▲ 227%
2024 · €19k
2018: €20k
2019: €20k
2020: €20k
2021: €20k
2022: €19k
2023: €19k
2024: €19k
2018 → 2025
Total assets
€827k▼ 39.5%
2024 · €1.37M
2018: €701k
2019: €722k
2020: €774k
2021: €900k
2022: €1.07M
2023: €1.27M
2024: €1.37M
2018 → 2025
Net result
€42k▼ 80.1%
2024 · €212k
2018: €263k
2019: €293k
2020: €253k
2021: €422k
2022: €311k
2023: €418k
2024: €212k
2018 → 2025
Working capital
€110k
2024 · €-34k
2018: €26k
2019: €17k
2020: €18k
2021: €20k
2022: €7k
2023: €-33k
2024: €-34k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€20k-€19k▼ 9.1%€19k=€19k=€61k▲ 227%
Operating result€550k-€410k▼ 25.5%€559k▲ 36.4%€284k▼ 49.2%€54k▼ 81.1%
Net result€422k-€311k▼ 26.3%€418k▲ 34.4%€212k▼ 49.3%€42k▼ 80.1%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 81% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €827k
Fixed assets
€44k▼ 18.9%
Current assets
€783k▼ 40.3%
Equity and liabilities €827k
Equity
€61k▲ 227%
Debt
€766k▼ 43.1%
The debt ratio falls from 98.6% to 92.6%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€82k▼
2024 · €307k
Cash flow
€71k▼
2024 · €235k
Solvency
7.4%▲
2024 · 1.4%
Current ratio
1.16▲
2024 · 0.97
Quick ratio
1.16▲
2024 · 0.97
Debt / equity
12.60▼
2024 · 72.42
ROE
69.4%
ROA
5.1%▼
2024 · 15.5%
Interest coverage
290.05▼
2024 · 295.88
Debt
€766k▼
2024 · €1.35M
Debt ≤ 1 year
€673k▼
2024 · €1.35M
Income taxes
€18k▼
2024 · €73k
Staff costs
€332k▲
2024 · €167k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€1.37M€827k▼
Fixed assets21/28€54k€44k▼
Tangible fixed assets22/27€54k€44k▼
Plant, machinery and equipment23€29k€24k▼
Furniture and vehicles24€25k€20k▼
Current assets29/58€1.31M€783k▼
Amounts receivable after more than one year29-€335k
Other amounts receivable291-€335k
Amounts receivable within one year40/41€1.01M€119k▼
Trade receivables40-€380
Other amounts receivable41€1.01M€119k▼
Current investments50/53€6k€6k=
Cash at bank and in hand54/58€20k€48k▲
Deferred charges and accrued income490/1€274k€276k▲
Equity and liabilities
Total equity and liabilities10/49€1.37M€827k▼
Equity10/15€19k€61k▲
Contributions10/11€19k€19k=
Reserves13-€42k
Distributable reserves133-€42k
Profit (loss) carried forward14€0€0=
Amounts payable17/49€1.35M€766k▼
Amounts payable within one year42/48€1.35M€673k▼
Financial debts43€0-
Credit institutions430/8€0-
Trade debts44€17k€50k▲
Suppliers440/4€17k€50k▲
Taxes, remuneration and social security45€53k€42k▼
Taxes450/3€34k€5k▼
Remuneration and social security454/9€19k€37k▲
Other amounts payable47/48€1.28M€581k▼
Accrued charges and deferred income492/3€1k€93k▲
Income statement
Code20242025
Remuneration, social security and pensions62€167k€332k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€23k€29k▲
Other operating charges640/8€935€751▼
Gross operating margin9900€475k€415k▼
Operating profit (loss)9901€284k€54k▼
Financial income75/76B€2k€7k▲
Recurring financial income75€2k€7k▲
Financial charges65/66B€1k€283▼
Recurring financial charges65€1k€283▼
Profit (loss) for the period before taxes9903€285k€60k▼
Income taxes67/77€73k€18k▼
Profit (loss) for the period9904€212k€42k▼
Profit (loss) for the period to be appropriated9905€212k€42k▼
Appropriation of the result
Profit (loss) to be appropriated9906€212k€42k▼
Transfer to equity691/2-€42k
To other reserves6921-€42k
Profit to be distributed694/7€212k€0▼
Return on contributions (dividend)694€212k€0▼
The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Weakest financial yearnet €42k ▼80.1%
Net result drops to €42k, the lowest in the series.
04-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
09-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 9 days late
2023
10-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
31-12
Financial
Highest result since 2018net €422k ▲66.9%
Net result €422k, the highest in the series.
28-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
10-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
15-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
28-06
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
15-06
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
no sitting director, no change since 2022
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
08-07-2022
Resigned as Director
Location & real-estate footprint
Registered office, Westerlo · 2 establishment units since 2013
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Boskant 182260 WesterloGround area
16.1 ha
Building footprint
3.9 ha
Volume, LiDAR
18,230 m³
2 parcels, Flanders · tallest building 14.0 m, ±3 floors. Linked by address, not a title deed.
2 establishment units
Heuppraktijk
since 20132.222.887.236
Heuppraktijk
since 20132.222.887.335
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71016I1216/00S000 | Flanders | 16.0 ha | 1 · 3.6 ha | - |
| 13049B0082/00Y003 | Flanders | 617 m² | 1 · 2,365 m² | 14.0 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Connections & network
2 connected companiesNetwork connections
Shared address
→
Shared address
→
Public money · subsidies and aid
Flemish government
2025 · 1 entry · 288 EUR awarded · 288 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 288 EUR | 288 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Similar companies · same sector, comparable size
NIKOLETTA DAOULARI, INTERNAL DOCTOR
BE 1005.267.913
Sint-Lambrechts-Woluwe · Eq €61k
MY DERMA CONSULT
BE 0730.888.169
Merchtem · Eq €61k
Dr Vandenbroucke Pédopsychiatrie
BE 0730.659.626
Thuin · Eq €61k
ONCO SENGY
BE 1025.592.282
Genappe · Eq €61k
DR. ANNE OOMEN
BE 0686.900.550
Wortegem-Petegem · Eq €61k
Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 5,424 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded21-08-2013
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 13 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.